Advocacy and Legislation in Breast Cancer Screening

Where breast screening policy actually gets decided

In this Voices of Experience webinar, Dianne Keen is joined by Kit Crancer, Senior VP of Public Policy at RAYUS and immediate past president of RBMA, and Miranda Franco, Senior Policy Advisor at Holland & Knight, for a working session on the policy shaping access to breast cancer screening. They open on the reimbursement pressure sitting underneath every access-to-care conversation, and on the coalition work being done to put evidence rather than sentiment in front of Congress and CMS.

From there the discussion moves to the gap patients feel most directly: the difference between a screening exam and the follow-up imaging that dense breast tissue or a personal history makes necessary, and what it costs a patient when that follow-up is billed as diagnostic. Kit and Miranda walk through the federal density notification requirement, the state coverage laws now on the books in more than twenty states, the Find It Early Act, and the prior authorization reforms changing how fast a payer has to answer.